Work

Akt inhibitor MK 2206 selectively targets CLL B ‐cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis

Year: 2013

Type: article

Abstract: Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis

Source: British Journal of Haematology

DOI: 10.1111/bjh.12564

Authors: Wei Ding, Tait D. Shanafelt, Connie E. Lesnick, Charles Erlichman, Jose F. Leis, Charla Secreto, Traci R. Sassoon, Timothy G. Call, Deborah A. Bowen, Michael Conte, Shaji Kumar, Neil E. Kay

Institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), Mayo Clinic in Arizona

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Leukemia and Lymphoma Society, National Cancer Institute

Awards: G1959417905, G3763356634, G426603385

OpenAlex ID: W2050426854

FWCI: 1.634

Cites: 10

Cited by: 21

Related to: 10